Purple Biotech Reported Preclinical Proof Of Concept Data For Its Conditionally-activated Tri-specific Antibody Platform
Purple Biotech报告了其条件激活的三特异性抗体平台的临床前概念验证数据
Purple Biotech Reported Preclinical Proof Of Concept Data For Its Conditionally-activated Tri-specific Antibody Platform
Purple Biotech报告了其条件激活的三特异性抗体平台的临床前概念验证数据
使用浏览器的分享功能,分享给你的好友吧